Skip to main content

Tables 4 Levels of oxidative DNA damage in TCCs on antioxidant supplementation

From: SENIEUR status of the originating cell donor negates certain ‘anti-immunosenescence’ effects of ebselen and N-acetyl cysteine in human T cell clone cultures

Time in culture (Weeks)

30 μM Ebselen (% of DNA in comet tail)

-

+

Alk

End

Fpg

Alk

End

Fpg

2

19.7 ± 0.6

21.6 ± 0.6

22.5 ± 0.6

20.6 ± 0.8

22.5 ± 0.8

23.5 ± 0.8

5

25.6 ± 0.6

27.6 ± 0.4

31.7 ± 0.8

26.3 ± 1.2

30.1 ± 1.0

32.0 ± 1.1

10

46.9 ± 0.6

48.8 ± 0.7

51.2 ± 1.2

48.8 ± 0.7

49.8 ± 0.6

51.8 ± 2.1

 

*

*

*

*

*

*

Time in culture (Weeks)

7.5 mM NAC (% of DNA in comet tail)

-

+

Alk

End

Fpg

Alk

End

Fpg

2

21.8 ± 0.8

22.6 ± 0.6

23.7 ± 0.3

22.2 ± 0.3

23.9 ± 0.1

24.2 ± 0.2

5

28.2 ± 1.6

30.8 ± 0.8

33.0 ± 1.2

27.7 ± 1.2

32.9 ± 0.8

34.1 ± 0.3

10

48.7 ± 0.4

49.9 ± 0.7

52.6 ± 1.0

50.2 ± 0.3

52.2 ± 1.2

53.6 ± 0.9

*

*

*

*

*

*

  1. The increase in levels of oxidative DNA damage in CD4+ TCC derived from a healthy 80 year old donor supplemented + / - 30 μM Ebselen or 7.5 mM NAC.
  2. *Significantly higher levels of oxidative DNA damage in week 10 on comparison with the earlier weeks (2 and 5). n = 3 pooled TCCs for each age group.